Andreas Jerrentrup
University of Marburg
27 Papers
200 Citations
Andreas Jerrentrup is an academic researcher from University of Marburg. The author has contributed to research in topics: Polysomnography & Medicine. The author has an hindex of 8, co-authored 27 publications.
Chat about Author
Papers
A prospective polysomnographic study on the evolution of complex sleep apnoea
Werner Cassel,Sebastian Canisius,Heinrich F. Becker,S. Leistner,Thomas Ploch,Andreas Jerrentrup,Claus Vogelmeier,Ulrich Koehler,Jörg Heitmann +8 more
TL;DR: Sleep quality was impaired and sleepiness was improved with CPAP, and was similar for patients with or without CompSA at diagnosis and follow-up, and is mainly observed in predisposed patients on nights with impaired sleep quality.
91
Automatic CPAP titration with different self-setting devices in patients with obstructive sleep apnoea.
Stammnitz A,Andreas Jerrentrup,Thomas Penzel,J. H. Peter,Claus Vogelmeier,Heinrich F. Becker +5 more
TL;DR: It is concluded that automatic continuous positive airway pressure devices produce a significant reduction in apnoea/hypopNoea index; however, there is considerable difference in the efficacy of the various devices.
54
Teaching medicine with the help of "Dr. House".
Andreas Jerrentrup,Tobias Mueller,Ulrich Glowalla,Meike Herder,Nadine Henrichs,Andreas Neubauer,Juergen R. Schaefer +6 more
TL;DR: Well performed medical TV shows such as Dr. House can successfully be used in an educational setting to motivate medical students to come into seminars to learn more about rare diseases.
Prehospital chest emergency sonography trial in Germany: a prospective study.
Albrecht Neesse,Andreas Jerrentrup,Saskia Hoffmann,Alexander Sattler,Christian Görg,Clemens Kill,Thomas Mathias Gress,Steffen Kunsch +7 more
TL;DR: Pleural effusion may serve as a novel prehospital marker for patients with decompensated CHF, thus facilitating the often difficult differential diagnosis between CHF and COPD.
43
Short-term Effects of Supplemental Oxygen on 6-Min Walk Test Outcomes in Patients With COPD A Randomized, Placebo-Controlled, Single-blind, Crossover Trial
Inga Jarosch,Rainer Gloeckl,Eva Damm,Anna-Lena Schwedhelm,David Buhrow,Andreas Jerrentrup,Martijn A. Spruit,Martijn A. Spruit,Klaus Kenn +8 more
TL;DR: In contrast to patients with NOX, patients with HYX and EIH generally benefit from supplemental oxygen by increasing exercise capacity, however, less than one‐half of patients reached the threshold of clinically relevant improvements.
36